Stay updated on AK104+Lenvatinib in Advanced Hepatocellular Carcinoma Clinical Trial
Sign up to get notified when there's something new on the AK104+Lenvatinib in Advanced Hepatocellular Carcinoma Clinical Trial page.

Latest updates to the AK104+Lenvatinib in Advanced Hepatocellular Carcinoma Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedNew user-help sections were added (How to Read a Study Record, Common Questions, How to Join a Study) and the page revision tag updated to v3.6.0. A recruitment status note now states the study is no longer looking for participants.SummaryDifference0.4%

- Check17 days agoChange DetectedThe page revision was updated from v3.5.4 to v3.5.5, indicating a new build/version of the page. The visible study content appears unchanged.SummaryDifference0.1%

- Check39 days agoChange DetectedA new revision tag 'Revision: v3.5.4' has been added, replacing the previous 'Revision: v3.5.3' to reflect a minor site update.SummaryDifference0.1%

- Check61 days agoChange DetectedThe page footer “Revision” value was updated from v3.5.2 to v3.5.3, indicating a platform release rather than a change to the clinical trial details shown on the page.SummaryDifference0.1%

- Check68 days agoChange DetectedRevision updated to v3.5.2; v3.5.0 was removed.SummaryDifference0.1%

- Check97 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

Stay in the know with updates to AK104+Lenvatinib in Advanced Hepatocellular Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the AK104+Lenvatinib in Advanced Hepatocellular Carcinoma Clinical Trial page.